Seeking to recover from sensational marketing scandals, GlaxoSmithKline did something unexpected five years ago — the company promised it would no longer pay doctors to promote its medicines, which had been a long-standing industry practice.

The move came not long after Glaxo paid $3 billion in fines in the U.S. for illegal marketing and kickbacks, among other things, and also followed reports the company showered doctors and government officials in China with bribes. With its announcement, Glaxo won praise for setting a new tone and raised hopes other drug makers would follow suit.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Let’s not forget that big pharma carries out a great deal of selective reporting and data mischaracterization when conducting and publishing drug trials. Also, many of these drugs seem to “work” only due to expectations people have that a drug would work (i.e., they work due to the “placebo effect”). The following reviews have shown that most active drugs and placebos have similar effect sizes (especially for health conditions that have a continuous outcomes):

    Howick J, et al. (2013) Are Treatments More Effective than Placebos? A Systematic Review and Meta-Analysis. PLoS ONE 8(5): e62599.

    Kirsch, I. (2014). Antidepressants and the Placebo Effect. Zeitschrift Fur Psychologie. 222, 128-134.

    As I see it, unless we do something now, these drugs are going to gradually build up in our ground water resources and poison us all..

  • When I was diagnosed with a chronic disease, the specialist who diagnosed and treated me put me on a newly approved drug touted as the first of its type. When I began experiencing serious side effects I contacted him but was repeatedly told it wasn’t a problem. Finally when I developed severe hypertension I stopped taking the drug and found another doctor. Later that year I learned of the FDA website that discloses how much doctors receive from the drug companies. My former doctor had received over $500,000 from the drug company that made the one he’d prescribed.

  • In Post fact America the things that used to be illegal are encouraged now. The industry insiders and Pharma Executives, that are now deregulating our healthcare system, normalized all of this. The US is the only developed nation where life expectancy is going down, while suicide rates increase. Welcome to the Kleptocracy. These powerful criminal organizations, fund the only patient advocacy there is, because it is profitable. They have undermined public trust, and enriched themselves on the suffering and deaths of Americans. We need Universal Healthcare, doing away with this greed corruption and theft will save us all billions.

    • To Mavis Johnson – It’s not that easy. Once you remove profitability from the equation, who will make the new life saving drugs of tomorrow? We need to look at how the drugs are made available. These middlemen (PBMs) who handle, ship and store the final product make $ Billions and never invested a dime in the actual research. A new drug costs more than $1 Billion to develop, not including all the failed compounds that never make it. It’s expensive to keep drug development safe. One more thing, if you crush the pharma industry as you suggested US unemployment would go through the roof and more than likely a massive recession would follow. Try having universal healthcare with an additional 3-5 million former taxpayers without a job. No money, no new drugs and no healthcare – great solution…

    • FYI: GSK is a British company. Sure the American healthcare system has its problems, but I’m not sure how your comment is entirely relevant in the context of this article about a non-American company.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy